- 全部删除
- 您的购物车当前为空
Anti-KNG1 Polyclonal Antibody 是一种 Rabbit 抗体,靶向 KNG1。Anti-KNG1 Polyclonal Antibody 可用于 WB。
Anti-KNG1 Polyclonal Antibody 是一种 Rabbit 抗体,靶向 KNG1。Anti-KNG1 Polyclonal Antibody 可用于 WB。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
50 μL | ¥ 1,165 | 5日内发货 | |
100 μL | ¥ 1,970 | 5日内发货 | |
200 μL | ¥ 2,790 | 5日内发货 |
产品描述 | Anti-KNG1 Polyclonal Antibody is a Rabbit antibody targeting KNG1. Anti-KNG1 Polyclonal Antibody can be used in WB. |
疾病造模方案 | |
别名 | Williams-Fitzgerald-Flaujeac Factor, lpha-2-Thiol Proteinase Inhibitor, KNG1, KNG, Kininogen-1, HMWK, High Molecular Weight Kininogen, Fitzgerald Factor, BDK |
Ig Type | IgG |
交叉反应 | Human (predicted:Mouse,Rat,Dog,Pig,Cow,Horse,Rabbit,Sheep) |
验证活性 | Sample: Lane 1: Human HepG2 cell lysates Primary: Anti-Bradykinin (TMAB-01033) at 1/1000 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size: 1.5/28/41/70 kDa Observed band size: 75 kDa |
应用 | |
推荐剂量 | WB: 1:500-2000 |
抗体种类 | Polyclonal |
宿主来源 | Rabbit |
亚细胞定位 | Secreted, extracellular space. |
组织特异性 | Secreted in plasma. T-kinin is detected in malignant ovarian, colon and breast carcinomas, but not in benign tumors. |
构建方式 | Polyclonal Antibody |
纯化方式 | Protein A purified |
性状 | Liquid |
缓冲液 | 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
浓度 | 1 mg/mL |
研究背景 | This gene uses alternative splicing to generate two different proteins- high molecular weight kininogen (HMWK) and low molecular weight kininogen (LMWK). HMWK is essential for blood coagulation and assembly of the kallikrein-kinin system. Also, bradykinin, a peptide causing numerous physiological effects, is released from HMWK. In contrast to HMWK, LMWK is not involved in blood coagulation. Three transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Oct 2009]. |
免疫原 | KLH conjugated synthetic peptide: human Kininogen 1 |
抗原种属 | Human |
基因名称 | KNG1 |
基因ID | |
蛋白名称 | Kininogen-1 |
Uniprot ID | |
功能 | Kininogens are inhibitors of thiol proteases; (2) HMW-kininogen plays an important role in blood coagulation by helping to position optimally prekallikrein and factor XI next to factor XII; (3) HMW-kininogen inhibits the thrombin- and plasmin-induced aggregation of thrombocytes; (4) the active peptide bradykinin that is released from HMW-kininogen shows a variety of physiological effects: (4A) influence in smooth muscle contraction, (4B) induction of hypotension, (4C) natriuresis and diuresis, (4D) decrease in blood glucose level, (4E) it is a mediator of inflammation and causes (4E1) increase in vascular permeability, (4E2) stimulation of nociceptors (4E3) release of other mediators of inflammation (e.g. prostaglandins), (4F) it has a cardioprotective effect (directly via bradykinin action, indirectly via endothelium-derived relaxing factor action); (5) LMW-kininogen inhibits the aggregation of thrombocytes; (6) LMW-kininogen is in contrast to HMW-kininogen not involved in blood clotting. |
分子量 | Theoretical: 1.5/28/41/70 kDa. |
储存方式 | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
运输方式 | Shipping with blue ice. |
评论内容